Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2014
09/03/2014EP2770997A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/02/2014US8822688 Imidazo[1,2-a]pyridine derivative
09/02/2014US8822684 Compounds and methods useful for directing stem cell differentiation
09/02/2014US8822683 CDK inhibitors
09/02/2014US8822677 Compositions and methods of making a photoactive agent
09/02/2014US8822510 Substituted 3-phenyl-1,2,4-Oxadiazole compounds
09/02/2014US8822495 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
09/02/2014US8822483 Six-membered N-heterocyclic carbene-based catalysts for asymmetric reactions
09/02/2014US8822481 Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
09/02/2014US8822479 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
09/02/2014US8822468 3-Methyl-imidazo[1,2-b]pyridazine derivatives
09/02/2014US8822459 Compound containing basic group and use thereof
09/02/2014US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
09/02/2014US8822448 Pyrazoloquinoline compound
09/02/2014US8822447 Indazole compounds useful as ketohexokinase inhibitors
08/2014
08/28/2014WO2014128612A1 Quinazolin-4-one derivatives
08/28/2014WO2014128591A1 Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (jak)
08/28/2014WO2014128093A1 Substituted-imidazo[1,2-b]pyridazines as mknk1 inhibitors
08/28/2014WO2014081821A3 Small Molecule Bicyclic and Tricyclic CFTR Correctors
08/28/2014WO2013138568A8 Liver x receptor modulators
08/28/2014US20140243360 Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors
08/28/2014US20140243357 Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
08/28/2014US20140243355 Inhibitors of bruton's tyrosine kinase
08/28/2014US20140243347 SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
08/28/2014US20140243336 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
08/28/2014US20140243322 Bivalent bromodomain ligands, and methods of using same
08/28/2014US20140243321 Bioorthogonal monomers capable of dimerizing and targeting bromodomains, and methods of using same
08/28/2014US20140243320 Novel compound having parp inhibitory activity
08/28/2014US20140243318 Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/28/2014US20140243315 Pyrrolopyrimidine compounds for the treatment of cancer
08/28/2014US20140243313 Tricyclic compounds useful as neurogenic and neuroprotective agents
08/28/2014US20140243312 Pyrrolo[2,3-d]pyrimidine derivatives
08/28/2014US20140243308 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/28/2014US20140243306 Novel pyrrolo pyrimidine derivatives
08/28/2014US20140243295 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
08/28/2014US20140243290 Aminopyrimidines as SYK Inhibitors
08/28/2014US20140243288 Fused ring-containing oxazolidinones antibiotics
08/28/2014US20140243281 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
08/27/2014EP2768834A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
08/27/2014EP2768833A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
08/27/2014EP2768832A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators
08/27/2014EP2768831A1 A compound for the treatment of hepatitis c
08/27/2014EP2768827A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768500A2 Treatment of cancer with tor kinase inhibitors
08/26/2014US8815933 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
08/26/2014US8815932 Induction of alpha helix conformations in proteins and peptides
08/26/2014US8815927 Bivalent diazo bicyclic Smac mimetics and the uses thereof
08/26/2014US8815926 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
08/26/2014US8815874 Pyrazolopyrimidine derivative
08/26/2014US8815873 Heterocyclic amides as rock inhibitors
08/26/2014US8815872 Macrocyclics pyrimidines as aurora kinase inhibitors
08/26/2014US8815869 Lactam acetamides as calcium channel blockers
08/26/2014US8815858 Heterocyclic flaviviridae virus inhibitors
08/26/2014US8815853 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
08/26/2014US8815418 Compound including fluorenyl group for organic photoelectric device and organic photoelectric device including the same
08/21/2014WO2014127331A1 Novel uses
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/21/2014WO2014124757A1 Pyrrolotriazine derivatives as pi3k inhibitors
08/21/2014WO2014100620A3 Compounds and methods for kinase modulation, and indications therefor
08/21/2014WO2014086453A8 Azaheterobicyclic compounds
08/21/2014US20140235853 Method of Preparation of epsilon-2,4,6,8,10,12-Hexanitro-2,4,6,8,10,12-Hexaazaisowurtzitane with Reduced Impact Sensitivity
08/21/2014US20140235647 Substituted bicyclic heteroaryl compounds
08/21/2014US20140235632 Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders
08/21/2014US20140235628 Inhibitors of the Renal Outer Medullary Potassium Channel
08/21/2014US20140235620 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
08/21/2014US20140235604 Compounds and methods of treating ocular disorders
08/21/2014US20140235581 Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
08/21/2014US20140234346 Pyrrolobenzodiazepines
08/21/2014US20140234254 Heteroaromatic compounds as pi3 kinase modulators and methods of use
08/20/2014EP2767537A1 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
08/20/2014EP2767536A1 Isoxazolo-pyridine derivatives
08/20/2014EP2766369A2 Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof
08/20/2014EP2766368A1 5,7-substituted-imidazo[1,2-c]pyrimidines
08/20/2014EP2766367A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and their use as antiviral active substances
08/20/2014EP2766366A1 Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
08/20/2014EP2766365A1 Antiviral compounds
08/20/2014EP2766361A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases
08/20/2014EP2766359A2 Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
08/20/2014EP2766358A1 Novel oxazine derivatives and their use in the treatment of disease
08/20/2014EP2766346A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766345A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/20/2014EP2766048A1 Pyrrolobenzodiazepines and conjugates thereof
08/19/2014US8809552 Azetidine compounds, compositions and methods of use
08/19/2014US8809527 Modulators of toll-like receptors
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809381 Highly selective sigma receptor ligands
08/19/2014US8809365 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
08/19/2014US8809355 GABAA receptor modulators
08/19/2014US8809352 Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer
08/19/2014US8809348 6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines
08/19/2014US8809345 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
08/19/2014US8809328 Imidazole derivative
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809321 Diaryl ether linked pyrrolo [2,1-c][1,4] benzodiazepine hybrids and process for the preparation thereof
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014CA2627839C Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
08/14/2014WO2014123332A1 7h-pyrrolo[2,3-d]pyrimidine-4-thiol derivative useful as jak-3 inhibitor
08/14/2014WO2014122160A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/14/2014WO2014122067A1 New indanyloxydihydrobenzofuranylacetic acids
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 573